The company's subsidiary, xinlitai, with a capital increase of RMB 550 million, began to fight back
Time of Update: 2017-12-08
Source: Xinkangjie 2017-12-08 medical network December 8 news "recently, xinlitai released a notice to increase its own capital of RMB 550 million to Suzhou Jinmeng Biotechnology
Two kinds of oral hypoglycemic compound preparations have entered the country one after another! There are many new drug approval highlights in the near future
Time of Update: 2017-04-26
Last week, four new class 1 drugs were approved for clinical use: sh229 tablets, InBev sodium tablets, shenggliptin phosphate tablets and zsp1602 capsules.
Arena's low-cost transfer of weight-loss drug belviq: changes in the pharmaceutical industry
Time of Update: 2017-01-05
- China Pharmaceutical source on January 5, 2017 [news event]: today, arena, an American biotechnology company, announced that it would sell its weight-loss
[summit person] Gong Zhaolong: exploring the new trend of FDA drug approval
Time of Update: 2016-09-14
Gong Zhaolong once worked as a new drug reviewer in the drug review center (CDER) of the U.S
Food and Drug Administration (USFDA), and served as the pre
Dndi's sunflower classic
Time of Update: 2016-08-30
The drugs developed by dndi are all tropical infectious diseases with a large population but few standard therapies.
Only me only can save Chinese new drugs
Time of Update: 2015-11-02
Moreover, if such a model has the opportunity, why don't foreign companies push their back-up projects into the market at the same time of their own initial drug development?
China's generic drugs set off the next international business opportunity
Time of Update: 2015-10-15
Source: pharmaceutical economic news 2015-10-14 Hengrui cyclophosphamide accounts for 40% of the market share of basic leukemia drugs in the United States, and oxaliplatin
Application for production of 1.1 new hypoglycemic drug of Hengrui medicine
Time of Update: 2015-06-09
1.1 class 1 new drug regolitine is applied for production, and its long-term income is expected to exceed 1 billion yuan.
ADA 2015: diabetes is still the world's major disease, calling for breakthrough drugs / outcome evidence
Time of Update: 2015-06-08
Another factor that makes it difficult for new diabetes drugs to grow is the effect of insulin on diabetes.
CDE drug review weekly report (April 19, 2015 to April 25, 2015
Time of Update: 2015-04-27
This week, the first clinical application for 2 drugs in category 3.1 of Qilu pharmaceutical was applied for: trogliptin succinate and its tablets and pabulib and its capsules.
Prospect of best selling drugs and hot treatment fields in 2015 (with ranking of drug market potential in 2015
Time of Update: 2014-12-15
According to the analysis of the analyst of evaluate Pharma, the most potential new drug is PD1 inhibitor (trade name: opdivo) of cellular immunotherapy used by Bristol Myers Squibb for cancer treatment.
Shortage of money and shortage of funds in biomedical industry
Time of Update: 2014-01-23
2014-01-23 source: for the appearance of a biological medicine in science times, the industry summarized it as "one billion dollars, ten years"
Due to the constraints